Literature DB >> 33242422

Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.

Ramita Dewan1, Ruth Chia1, Jinhui Ding2, Richard A Hickman3, Thor D Stein4, Yevgeniya Abramzon5, Sarah Ahmed6, Marya S Sabir6, Makayla K Portley6, Arianna Tucci7, Kristina Ibáñez7, F N U Shankaracharya8, Pamela Keagle8, Giacomina Rossi9, Paola Caroppo9, Fabrizio Tagliavini10, Maria L Waldo11, Per M Johansson12, Christer F Nilsson13, James B Rowe14, Luisa Benussi15, Giuliano Binetti16, Roberta Ghidoni15, Edwin Jabbari17, Coralie Viollet18, Jonathan D Glass19, Andrew B Singleton20, Vincenzo Silani21, Owen A Ross22, Mina Ryten23, Ali Torkamani24, Toshiko Tanaka25, Luigi Ferrucci25, Susan M Resnick26, Stuart Pickering-Brown27, Christopher B Brady28, Neil Kowal29, John A Hardy30, Vivianna Van Deerlin31, Jean Paul Vonsattel3, Matthew B Harms32, Huw R Morris17, Raffaele Ferrari33, John E Landers8, Adriano Chiò34, J Raphael Gibbs2, Clifton L Dalgard35, Sonja W Scholz36, Bryan J Traynor37.   

Abstract

We examined the role of repeat expansions in the pathogenesis of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) by analyzing whole-genome sequence data from 2,442 FTD/ALS patients, 2,599 Lewy body dementia (LBD) patients, and 3,158 neurologically healthy subjects. Pathogenic expansions (range, 40-64 CAG repeats) in the huntingtin (HTT) gene were found in three (0.12%) patients diagnosed with pure FTD/ALS syndromes but were not present in the LBD or healthy cohorts. We replicated our findings in an independent collection of 3,674 FTD/ALS patients. Postmortem evaluations of two patients revealed the classical TDP-43 pathology of FTD/ALS, as well as huntingtin-positive, ubiquitin-positive aggregates in the frontal cortex. The neostriatal atrophy that pathologically defines Huntington's disease was absent in both cases. Our findings reveal an etiological relationship between HTT repeat expansions and FTD/ALS syndromes and indicate that genetic screening of FTD/ALS patients for HTT repeat expansions should be considered. Published by Elsevier Inc.

Entities:  

Keywords:  amyotrophic lateral sclerosis; frontotemporal dementia; huntingtin; repeat expansions; whole-genome sequencing

Mesh:

Substances:

Year:  2020        PMID: 33242422      PMCID: PMC7864894          DOI: 10.1016/j.neuron.2020.11.005

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   18.688


  56 in total

1.  Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.

Authors:  Mari Tada; Elizabeth A Coon; Alexander P Osmand; Patricia A Kirby; Wayne Martin; Marguerite Wieler; Atsushi Shiga; Hiroe Shirasaki; Masayoshi Tada; Takao Makifuchi; Mitsunori Yamada; Akiyoshi Kakita; Masatoyo Nishizawa; Hitoshi Takahashi; Henry L Paulson
Journal:  Acta Neuropathol       Date:  2012-06-27       Impact factor: 17.088

2.  Integrating common and rare genetic variation in diverse human populations.

Authors:  David M Altshuler; Richard A Gibbs; Leena Peltonen; David M Altshuler; Richard A Gibbs; Leena Peltonen; Emmanouil Dermitzakis; Stephen F Schaffner; Fuli Yu; Leena Peltonen; Emmanouil Dermitzakis; Penelope E Bonnen; David M Altshuler; Richard A Gibbs; Paul I W de Bakker; Panos Deloukas; Stacey B Gabriel; Rhian Gwilliam; Sarah Hunt; Michael Inouye; Xiaoming Jia; Aarno Palotie; Melissa Parkin; Pamela Whittaker; Fuli Yu; Kyle Chang; Alicia Hawes; Lora R Lewis; Yanru Ren; David Wheeler; Richard A Gibbs; Donna Marie Muzny; Chris Barnes; Katayoon Darvishi; Matthew Hurles; Joshua M Korn; Kati Kristiansson; Charles Lee; Steven A McCarrol; James Nemesh; Emmanouil Dermitzakis; Alon Keinan; Stephen B Montgomery; Samuela Pollack; Alkes L Price; Nicole Soranzo; Penelope E Bonnen; Richard A Gibbs; Claudia Gonzaga-Jauregui; Alon Keinan; Alkes L Price; Fuli Yu; Verneri Anttila; Wendy Brodeur; Mark J Daly; Stephen Leslie; Gil McVean; Loukas Moutsianas; Huy Nguyen; Stephen F Schaffner; Qingrun Zhang; Mohammed J R Ghori; Ralph McGinnis; William McLaren; Samuela Pollack; Alkes L Price; Stephen F Schaffner; Fumihiko Takeuchi; Sharon R Grossman; Ilya Shlyakhter; Elizabeth B Hostetter; Pardis C Sabeti; Clement A Adebamowo; Morris W Foster; Deborah R Gordon; Julio Licinio; Maria Cristina Manca; Patricia A Marshall; Ichiro Matsuda; Duncan Ngare; Vivian Ota Wang; Deepa Reddy; Charles N Rotimi; Charmaine D Royal; Richard R Sharp; Changqing Zeng; Lisa D Brooks; Jean E McEwen
Journal:  Nature       Date:  2010-09-02       Impact factor: 49.962

Review 3.  Coexistence of Huntington's disease and familial amyotrophic lateral sclerosis: case presentation.

Authors:  A Rubio; K Steinberg; D A Figlewicz; M E MacDonald; T Greenamyre; R Hamill; I Shoulson; J M Powers
Journal:  Acta Neuropathol       Date:  1996-10       Impact factor: 17.088

4.  Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

Authors:  Laura Kennedy; Elizabeth Evans; Chiung-Mei Chen; Lyndsey Craven; Peter J Detloff; Margaret Ennis; Peggy F Shelbourne
Journal:  Hum Mol Genet       Date:  2003-10-21       Impact factor: 6.150

5.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

6.  Genetically confirmed Huntington's disease masquerading as motor neuron disease.

Authors:  Kazuaki Kanai; Satoshi Kuwabara; Setsu Sawai; Miho Nakata; Sonoko Misawa; Sagiri Isose; Shigeki Hirano; Naoki Kawaguchi; Kaoru Katayama; Takamichi Hattori
Journal:  Mov Disord       Date:  2008-04-15       Impact factor: 10.338

7.  Second-generation PLINK: rising to the challenge of larger and richer datasets.

Authors:  Christopher C Chang; Carson C Chow; Laurent Cam Tellier; Shashaank Vattikuti; Shaun M Purcell; James J Lee
Journal:  Gigascience       Date:  2015-02-25       Impact factor: 6.524

8.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

9.  Projected increase in amyotrophic lateral sclerosis from 2015 to 2040.

Authors:  Karissa C Arthur; Andrea Calvo; T Ryan Price; Joshua T Geiger; Adriano Chiò; Bryan J Traynor
Journal:  Nat Commun       Date:  2016-08-11       Impact factor: 14.919

10.  Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1.

Authors:  Ricardo Mouro Pinto; Larissa Arning; James V Giordano; Pedram Razghandi; Marissa A Andrew; Tammy Gillis; Kevin Correia; Jayalakshmi S Mysore; Debora-M Grote Urtubey; Constanze R Parwez; Sarah M von Hein; H Brent Clark; Huu Phuc Nguyen; Eckart Förster; Allison Beller; Suman Jayadaev; C Dirk Keene; Thomas D Bird; Diane Lucente; Jean-Paul Vonsattel; Harry Orr; Carsten Saft; Elisabeth Petrasch-Parwez; Vanessa C Wheeler
Journal:  Hum Mol Genet       Date:  2020-08-29       Impact factor: 6.150

View more
  17 in total

1.  Huntington's disease: lessons from prion disorders.

Authors:  Melanie Alpaugh; Francesca Cicchetti
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

Review 2.  Recent advancements in chromone as a privileged scaffold towards the development of small molecules for neurodegenerative therapeutics.

Authors:  Hari Madhav; Ehtesham Jameel; Mohammad Rehan; Nasimul Hoda
Journal:  RSC Med Chem       Date:  2022-01-31

Review 3.  Neurogenetic disorders across the lifespan: from aberrant development to degeneration.

Authors:  Richard A Hickman; Sarah A O'Shea; Mark F Mehler; Wendy K Chung
Journal:  Nat Rev Neurol       Date:  2022-01-05       Impact factor: 42.937

4.  Amyotrophic lateral sclerosis is over-represented in two Huntington's disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion.

Authors:  Richard A Hickman; Ramita Dewan; Etty Cortes; Bryan J Traynor; Karen Marder; Jean-Paul Vonsattel
Journal:  Acta Neuropathol       Date:  2021-11-20       Impact factor: 17.088

5.  GRN Mutations Are Associated with Lewy Body Dementia.

Authors:  Paolo Reho; Shunsuke Koga; Zalak Shah; Ruth Chia; Rosa Rademakers; Clifton L Dalgard; Bradley F Boeve; Thomas G Beach; Dennis W Dickson; Owen A Ross; Sonja W Scholz
Journal:  Mov Disord       Date:  2022-07-10       Impact factor: 9.698

6.  Motoneuron Diseases.

Authors:  Francesco Lotti; Serge Przedborski
Journal:  Adv Neurobiol       Date:  2022

Review 7.  Combating deleterious phase transitions in neurodegenerative disease.

Authors:  April L Darling; James Shorter
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2021-02-05       Impact factor: 4.739

8.  Sensory neuropathy due to RFC1 in a patient with ALS: more than a coincidence?

Authors:  Florian Schoeberl; Angela Abicht; Clemens Kuepper; Stefanie Voelk; Stefan Sonnenfeld; Matthias Tonon; Annalisa Schaub; Veronika Scholz; Stephanie Kleinle; Hannes Erdmann; Dieter A Wolf; Peter Reilich
Journal:  J Neurol       Date:  2021-11-25       Impact factor: 6.682

Review 9.  Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

Review 10.  Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.

Authors:  Stephen A Goutman; Orla Hardiman; Ammar Al-Chalabi; Adriano Chió; Masha G Savelieff; Matthew C Kiernan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2022-03-22       Impact factor: 59.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.